A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Novavax Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 88,926 shares of NVAX stock, worth $800,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares
88,926
Previous 88,926 -0.0%
Holding current value
$800,334
Previous $1.12 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$3.89 - $20.97 $16,676 - $89,898
-4,287 Reduced 4.6%
88,926 $1.13 Million
Q1 2024

Apr 25, 2024

BUY
$3.76 - $6.02 $20,582 - $32,953
5,474 Added 6.24%
93,213 $445,000
Q4 2023

Jan 30, 2024

BUY
$4.8 - $7.67 $131,692 - $210,434
27,436 Added 45.5%
87,739 $421,000
Q3 2023

Oct 25, 2023

BUY
$6.81 - $9.74 $310,358 - $443,890
45,574 Added 309.42%
60,303 $436,000
Q2 2023

Aug 07, 2023

BUY
$6.67 - $9.52 $12,993 - $18,544
1,948 Added 15.24%
14,729 $109,000
Q1 2023

May 08, 2023

BUY
$5.76 - $12.48 $247 - $536
43 Added 0.34%
12,781 $88,000
Q4 2022

Feb 01, 2023

SELL
$8.86 - $25.04 $13,910 - $39,312
-1,570 Reduced 10.97%
12,738 $130,000
Q3 2022

Nov 09, 2022

SELL
$18.2 - $76.12 $191,482 - $800,858
-10,521 Reduced 42.37%
14,308 $260,000
Q2 2022

Aug 09, 2022

SELL
$36.28 - $75.29 $1.1 Million - $2.29 Million
-30,390 Reduced 55.04%
24,829 $1.28 Million
Q1 2022

Apr 21, 2022

BUY
$69.73 - $142.9 $2.1 Million - $4.3 Million
30,109 Added 119.91%
55,219 $4.07 Million
Q4 2021

Feb 01, 2022

BUY
$134.56 - $217.97 $481,052 - $779,242
3,575 Added 16.6%
25,110 $3.59 Million
Q3 2021

Nov 15, 2021

BUY
$177.8 - $270.58 $312,394 - $475,409
1,757 Added 8.88%
21,535 $4.46 Million
Q2 2021

Jul 30, 2021

BUY
$121.0 - $257.67 $1.47 Million - $3.12 Million
12,108 Added 157.86%
19,778 $4.2 Million
Q1 2021

May 03, 2021

SELL
$112.98 - $319.93 $139,191 - $394,153
-1,232 Reduced 13.84%
7,670 $1.39 Million
Q4 2020

Jan 28, 2021

BUY
$78.74 - $139.5 $186,456 - $330,336
2,368 Added 36.24%
8,902 $993,000
Q3 2020

Nov 06, 2020

BUY
$79.44 - $178.51 $74,673 - $167,799
940 Added 16.8%
6,534 $708,000
Q2 2020

Jul 28, 2020

BUY
$13.86 - $83.61 $77,532 - $467,714
5,594 New
5,594 $466,000
Q4 2019

Jan 21, 2020

SELL
$3.69 - $5.22 $5,143 - $7,276
-1,394 Closed
0 $0
Q2 2019

Jul 30, 2019

BUY
$4.93 - $12.2 $6,872 - $17,006
1,394 New
1,394 $8,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $704M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.